A new human adipocyte model with PTEN haploinsufficiency

Area of Science:

• Cell Biology
• Endocrinology
• Genetics

Background:

• Limited availability of suitable human *in vitro* adipocyte models.
• Need for cell lines with defined genetic characteristics for studying adipocyte biology.

Purpose of the Study:

• Establish and characterize a novel human preadipocyte cell strain, LipPD1, derived from lipoma tissue.
• Compare the cellular functions and signaling pathways of LipPD1 with established models like Simpson-Golabi-Behmel-Syndrome (SGBS) adipocytes and primary stromal-vascular fraction cells.
• Investigate the impact of germline phosphatase and tensin homolog (PTEN) haploinsufficiency on adipocyte biology.

Main Methods:

• Isolation and culture of preadipocytes from lipoma tissue of a patient with PTEN haploinsufficiency.
• Adipogenic differentiation assays to assess differentiation capacity.
• Analysis of adipocyte-specific functions and cellular life span.
• Western blot analysis to determine protein levels and signaling pathway activation (PI3K/AKT/PTEN).

Main Results:

• LipPD1 cells demonstrated a preserved cellular life span and adipocyte differentiation capacity comparable to SGBS adipocytes.
• Adipocyte-specific functions were maintained in LipPD1 cells.
• Increased basal and growth factor-stimulated activation of the PI3K/AKT signaling pathway was observed in LipPD1 preadipocytes, correlating with reduced PTEN levels.

Conclusions:

• LipPD1 cells represent a novel, well-characterized primary human cell model with a defined genetic lesion (PTEN haploinsufficiency).
• This model is suitable for investigating adipocyte biology and the role of the PI3K/AKT/PTEN pathway.
• LipPD1 offers a valuable alternative to existing adipocyte models for *in vitro* research.